データなし
データなし
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa Gene Therapy in Combination With Tecentriq in Extensive Stage Small Cell Lung Cancer
Genprex Signs Exclusive License to Additional Gene Therapy Technologies With the University of Michigan for the Treatment of Lung Cancer
ジェンプレックス | 10-Q:Q3 2024 四半期報告書
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
Genprex to Participate in 2024 BIO Europe Conference
12 Health Care Stocks Moving In Monday's Intraday Session